Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
57,61 USD | -1,50 % | +2,35 % | -3,20 % |
Resumen de negocios
Número de empleados: 704
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutic Compounds
100,0
%
| 75 | 100,0 % | 397 | 100,0 % | +425,83 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 75 | 100,0 % | 397 | 100,0 % | +425,83 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 54 | 25/09/09 | |
Cedric Francois
FOU | Founder | 51 | 25/09/09 |
Timothy Sullivan
DFI | Director of Finance/CFO | 53 | 01/10/17 |
Caroline Baumal
CTO | Chief Tech/Sci/R&D Officer | 57 | 03/01/23 |
Adam Townsend
COO | Chief Operating Officer | 47 | 20/11/18 |
Lukas Scheibler
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/04/19 |
Meredith Kaya
IRC | Investor Relations Contact | - | - |
Jeffrey Eisele
PRN | Corporate Officer/Principal | - | 01/01/20 |
Vahe Ghahraman
LAW | General Counsel | - | 01/04/19 |
Thomas Lackner
PRN | Corporate Officer/Principal | - | 31/01/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Alec Machiels
FOU | Founder | 51 | 25/09/09 |
Director/Board Member | 65 | 01/07/13 | |
Andrew Dunlop
BRD | Director/Board Member | 52 | 01/03/10 |
Cedric Francois
FOU | Founder | 51 | 25/09/09 |
Founder | 54 | 25/09/09 | |
Lok Chung Chan
CHM | Chairman | 73 | 01/07/13 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 120 581 749 | 104 624 536 ( 86,77 %) | 0 | 86,77 % |
Información de la empresa
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-3,20 % | 7052,83 M | |
+0,44 % | 90,27 mil M | |
+9,61 % | 44,05 mil M | |
-16,74 % | 31,45 mil M | |
+44,30 % | 23,35 mil M | |
-8,51 % | 16,72 mil M | |
-25,92 % | 15,09 mil M | |
-9,49 % | 12,82 mil M | |
-7,57 % | 11,95 mil M | |
+0,07 % | 8706,93 M |
- Bolsa
- Acciones
- Acción Apellis Pharmaceuticals, Inc. - Nasdaq
- Empresa Apellis Pharmaceuticals, Inc.